Internal Reference Number: FOI_8684
Date Request Received: 03/06/2025 00:00:00
Date Request Replied To: 08/07/2025 00:00:00
This response was sent via: By Email
Request Summary: pancreatic enzyme replacement therapy (PERT)
Request Category: Companies
| Question Number 1: Has your Trust procured any pancreatic enzyme replacement therapy (PERT) products from overseas suppliers between January 2023 and present? Please respond with yes or no. | |
| Answer To Question 1: Yes | |
| Question Number 2: If yes, please answer the following: Which countries were these products sourced from? | |
| Answer To Question 2: Australia | |
| Question Number 3: How many 'special order' prescriptions for these products have been dispensed? | |
| Answer To Question 3: 16 | |
| Question Number 4: What percentage of the local demand has been covered by these overseas products? | |
| Answer To Question 4: Approx 4% of local demand was covered by the overseas supply | |
| To return to the list of all the FOI requests please click here |
Our staff at Salisbury District Hospital have long been well regarded for the quality of care and treatment they provide for our patients and for their innovation, commitment and professionalism. This has been recognised in a wide range of achievements and it is reflected in our award of NHS Foundation Trust status. This is afforded to hospitals that provide the highest standards of care.
